Literature DB >> 12039950

Site-specific loss of acetylation upon phosphorylation of histone H3.

Diane G Edmondson1, Judith K Davie, Jenny Zhou, Banafsheh Mirnikjoo, Kelly Tatchell, Sharon Y R Dent.   

Abstract

Post-translational modification of histones is a central aspect of gene regulation. Emerging data indicate that modification at one site can influence modification of a second site. As one example, histone H3 phosphorylation at serine 10 (Ser(10)) facilitates acetylation of lysine 14 (Lys(14)) by Gcn5 in vitro (, ). In vivo, phosphorylation of H3 precedes acetylation at certain promoters. Whether H3 phosphorylation globally affects acetylation, or whether it affects all acetylation sites in H3 equally, is not known. We have taken a genetic approach to this question by mutating Ser(10) in H3 to fix either a negative or a neutral charge at this position, followed by analysis of the acetylation states of the mutant histones using site-specific antibodies. Surprisingly, we find that conversion of Ser(10) to glutamate (S10E) or aspartate (S10D) causes almost complete loss of H3 acetylation at lysine 9 (Lys(9)) in vivo. Acetylation of Lys(9) is also significantly reduced in cells bearing mutations in the Glc7 phosphatase that increase H3 phosphorylation levels. Mutation of Ser(10) in H3 and the concomitant loss of Lys(9) acetylation has minimal effects on expression of a Gcn5-dependent reporter gene. However, synergistic growth defects are observed upon loss of GCN5 in cells bearing H3 Ser(10) mutations that are reminiscent of delays in G(2)/M progression caused by combined loss of GCN5 and acetylation site mutations. Together these results demonstrate that H3 phosphorylation directly causes site-specific and opposite changes in acetylation levels of two residues within this histone, Lys(9) and Lys(14), and they highlight the importance of these histone modifications to normal cell functions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12039950     DOI: 10.1074/jbc.M200651200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Butyrate, an HDAC inhibitor, stimulates interplay between different posttranslational modifications of histone H3 and differently alters G1-specific cell cycle proteins in vascular smooth muscle cells.

Authors:  Omana P Mathew; Kasturi Ranganna; Frank M Yatsu
Journal:  Biomed Pharmacother       Date:  2010-12       Impact factor: 6.529

2.  Global control of histone modification by the anaphase-promoting complex.

Authors:  Vijay Ramaswamy; Jessica S Williams; Karen M Robinson; Richelle L Sopko; Michael C Schultz
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

3.  MSK2 and MSK1 mediate the mitogen- and stress-induced phosphorylation of histone H3 and HMG-14.

Authors:  Ana Soloaga; Stuart Thomson; Giselle R Wiggin; Navita Rampersaud; Mark H Dyson; Catherine A Hazzalin; Louis C Mahadevan; J Simon C Arthur
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

4.  Epigenetic regulation of thy-1 by histone deacetylase inhibitor in rat lung fibroblasts.

Authors:  Yan Y Sanders; Trygve O Tollefsbol; Brian M Varisco; James S Hagood
Journal:  Am J Respir Cell Mol Biol       Date:  2010-08-19       Impact factor: 6.914

5.  Distinctive signatures of histone methylation in transcribed coding and noncoding human beta-globin sequences.

Authors:  AeRi Kim; Christine M Kiefer; Ann Dean
Journal:  Mol Cell Biol       Date:  2006-12-11       Impact factor: 4.272

6.  Liquid chromatography mass spectrometry profiling of histones.

Authors:  Xiaodan Su; Naduparambil K Jacob; Ravindra Amunugama; David M Lucas; Amy R Knapp; Chen Ren; Melanie E Davis; Guido Marcucci; Mark R Parthun; John C Byrd; Richard Fishel; Michael A Freitas
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-01-07       Impact factor: 3.205

Review 7.  Multi-tasking on chromatin with the SAGA coactivator complexes.

Authors:  Jeremy A Daniel; Patrick A Grant
Journal:  Mutat Res       Date:  2007-01-21       Impact factor: 2.433

8.  DEK in the synovium of patients with juvenile idiopathic arthritis: characterization of DEK antibodies and posttranslational modification of the DEK autoantigen.

Authors:  Nirit Mor-Vaknin; Ferdinand Kappes; Amalie E Dick; Maureen Legendre; Catalina Damoc; Seagal Teitz-Tennenbaum; Roland Kwok; Elisa Ferrando-May; Barbara S Adams; David M Markovitz
Journal:  Arthritis Rheum       Date:  2011-02

9.  High-sensitivity TFA-free LC-MS for profiling histones.

Authors:  Jia You; Liwen Wang; Motoyasu Saji; Susan V Olesik; Matthew D Ringel; David M Lucas; John C Byrd; Michael A Freitas
Journal:  Proteomics       Date:  2011-08       Impact factor: 3.984

Review 10.  Mass spectrometry-based strategies for characterization of histones and their post-translational modifications.

Authors:  Xiaodan Su; Chen Ren; Michael A Freitas
Journal:  Expert Rev Proteomics       Date:  2007-04       Impact factor: 3.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.